Clinical Trial Update: A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluating the fixed-dose combination of valsartan and amlodipine for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED